MORGAN STANLEY - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 279 filers reported holding CONMED CORP in Q1 2022. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CONMED CORP
ValueSharesWeighting
Q3 2023$53,313,393
+30.7%
528,639
+76.1%
0.01%
+25.0%
Q2 2023$40,800,182
+59.3%
300,242
+21.8%
0.00%
+33.3%
Q1 2023$25,611,263
-38.0%
246,593
-47.1%
0.00%
-40.0%
Q4 2022$41,298,817
+95.8%
465,915
+77.1%
0.01%
+66.7%
Q3 2022$21,093,000
-3.6%
263,095
+15.1%
0.00%0.0%
Q2 2022$21,881,000
+16.2%
228,496
+80.3%
0.00%0.0%
Q1 2022$18,824,000
-0.8%
126,732
-5.3%
0.00%
+50.0%
Q4 2021$18,975,000
+14.6%
133,846
+5.8%
0.00%0.0%
Q3 2021$16,552,000
-7.6%
126,516
-3.0%
0.00%0.0%
Q2 2021$17,923,000
+55.7%
130,415
+48.0%
0.00%0.0%
Q1 2021$11,508,000
-1.1%
88,132
-15.2%
0.00%0.0%
Q4 2020$11,638,000
+68.4%
103,909
+18.3%
0.00%
+100.0%
Q3 2020$6,909,000
+2.1%
87,835
-6.5%
0.00%0.0%
Q2 2020$6,765,000
-60.2%
93,956
-68.3%
0.00%
-80.0%
Q1 2020$17,000,000
-39.9%
296,832
+17.4%
0.01%
-28.6%
Q4 2019$28,266,000
+127.7%
252,759
+95.8%
0.01%
+133.3%
Q3 2019$12,414,000
+3.7%
129,107
-7.7%
0.00%0.0%
Q2 2019$11,968,000
+359.8%
139,856
+346.8%
0.00%
+200.0%
Q1 2019$2,603,000
-27.6%
31,300
-44.1%
0.00%0.0%
Q4 2018$3,596,000
-82.5%
56,011
-78.4%
0.00%
-80.0%
Q3 2018$20,582,000
+59.7%
259,823
+47.6%
0.01%
+66.7%
Q2 2018$12,884,000
+168.2%
175,993
+131.9%
0.00%
+200.0%
Q1 2018$4,804,000
-28.3%
75,880
-42.3%
0.00%
-50.0%
Q4 2017$6,701,000
+29.9%
131,480
+33.7%
0.00%0.0%
Q3 2017$5,159,000
+29.9%
98,331
+26.1%
0.00%
+100.0%
Q2 2017$3,973,000
-21.1%
77,998
-31.2%
0.00%0.0%
Q1 2017$5,038,000
-52.7%
113,430
-53.0%
0.00%
-50.0%
Q4 2016$10,650,000
+3187.0%
241,110
+2888.5%
0.00%
Q3 2016$324,000
-44.0%
8,068
-33.6%
0.00%
Q2 2016$579,000
-20.5%
12,150
-30.1%
0.00%
Q1 2016$728,000
+92.6%
17,374
+102.7%
0.00%
Q4 2015$378,000
-86.5%
8,571
-85.4%
0.00%
-100.0%
Q3 2015$2,809,000
+102.8%
58,834
+147.5%
0.00%
Q2 2015$1,385,000
-67.8%
23,774
-72.1%
0.00%
-100.0%
Q1 2015$4,304,000
+7.1%
85,241
-4.6%
0.00%
+100.0%
Q4 2014$4,018,000
+117.2%
89,355
+77.9%
0.00%0.0%
Q3 2014$1,850,000
-59.5%
50,238
-51.5%
0.00%
-50.0%
Q2 2014$4,572,000
+92.7%
103,564
+89.7%
0.00%
+100.0%
Q1 2014$2,373,000
+463.7%
54,599
+452.2%
0.00%
Q4 2013$421,000
-75.0%
9,887
-80.1%
0.00%
-100.0%
Q3 2013$1,683,000
-57.0%
49,597
-60.4%
0.00%
-50.0%
Q2 2013$3,912,000125,1950.00%
Other shareholders
CONMED CORP shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 310,392$34,764,0004.40%
Iron Triangle Partners LP 148,317$16,612,0002.15%
Ranger Investment Management 294,664$33,002,0001.74%
Penn Capital Management Company, LLC 86,810$9,723,0001.23%
EARNEST PARTNERS LLC 1,575,336$176,438,0001.22%
Champlain Investment Partners, LLC 1,692,014$189,506,0001.09%
MOODY ALDRICH PARTNERS LLC 59,005$6,609,0001.07%
Hood River Capital Management LLC 232,412$26,030,0000.86%
OAK RIDGE INVESTMENTS LLC 80,775$9,047,0000.80%
Huber Capital Management LLC 18,620$2,085,0000.68%
View complete list of CONMED CORP shareholders